Dentsply Sirona
XRAY

$26.41

0.08%

Market Cap: 5.48B

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Employees: 15,000

Healthcare Dental Equipment & Supplies

0

Funds holding %

of 6,702 funds

0

Analysts bullish %

of 15 analysts

0

News positive %

of 25 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

103% more call options, than puts

Call options by funds: $4.85M | Put options by funds: $2.39M

43% more first-time investments, than exits

New positions opened: 80 | Existing positions closed: 56

16% more repeat investments, than reductions

Existing positions increased: 156 | Existing positions reduced: 135

6% more funds holding

Funds holding: 406 [Q4 2023] → 430 (+24) [Q1 2024]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q4 2023] → 3 (+0) [Q1 2024]

1.09% less ownership

Funds ownership: 100.12% [Q4 2023] → 99.03% (-1.09%) [Q1 2024]

10% less capital invested

Capital invested by funds: $7.55B [Q4 2023] → $6.82B (-$733M) [Q1 2024]

See Fund Rankings

Research analyst outlook

15 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target

$27

2%

upside

Avg. target

$35

32%

upside

High target

$42

59%

upside

15 analyst ratings

10 positive

67%

5 neutral

33%

0 negative

0%

Baird Jeffrey Johnson	17%upside $31	Neutral Maintained	22 Jul 2024
Stifel Jonathan Block	6%upside $28	Hold Maintained	18 Jul 2024
Evercore ISI Group Elizabeth Anderson	2%upside $27	Outperform Maintained	9 Jul 2024
Barrington Research Michael Petusky	44%upside $38	Outperform Maintained	8 Jul 2024
Evercore ISI Group Elizabeth Anderson	6%upside $28	Outperform Maintained	25 Jun 2024

See Analyst Rankings

Financial journalist opinion

Based on 25 articles about XRAY published over the past 30 days

Dentsply Sirona Inc Investors Are Called Upon By The Schall Law Firm To Join The Xray Inquiry

LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.

Dentsply Sirona Inc Investors Are Called Upon By The Schall Law Firm To Join The Xray Inquiry

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

Zacks Investment Research

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now

Columbia Dental Prosthetics Market Analysis Report 2024-2030, Featuring Key Players Dentsply Sirona, Ivoclar, New Stetic and VITA

Dublin, July 25, 2024 (GLOBE NEWSWIRE) -- The "Columbia Dental Prosthetics Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Crowns and Bridges, Inlays and Onlays, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, the dental prosthetics market in Colombia reached a valuation of more than $132 million. This market is projected to grow at a compound annual growth rate (CAGR) of 5.1%, nearing $188 million in the forecast period. The comprehensive report on the Colombian dental prosthetics market covers various segments, including crowns and bridges, dentures, denture teeth, CAD/CAM prosthetics, inlays and onlays, and veneers. DATA TYPES INCLUDED

Columbia Dental Prosthetics Market Analysis Report 2024-2030, Featuring Key Players Dentsply Sirona, Ivoclar, New Stetic and VITA

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

Zacks Investment Research

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.

DENTSPLY SIRONA Inc Investors Are Called Upon By The Schall Law Firm To Join The XRAY Inquiry

Brazil Dental Prosthetics Market Size, Share & Trends Analysis 2024-2030, Featuring Dentsply Sirona, Ivoclar, VITA and Kulzer

Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Brazil Dental Prosthetics Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Crowns and Bridges, Inlays and Onlays, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, the Brazilian dental prosthetics market was valued at more than $10.2 billion. This market is projected to grow at a compound annual growth rate (CAGR) of 5.2%, reaching nearly $14.7 billion over the forecast period. The comprehensive report on Brazil's dental prosthetics market encompasses various segments, including crowns and bridges, dentures, denture teeth, CAD/CAM prosthetics, inlays and onlays, and veneers. DATA TYPES INCLUDED

Brazil Dental Prosthetics Market Size, Share & Trends Analysis 2024-2030, Featuring Dentsply Sirona, Ivoclar, VITA and Kulzer

DENTSPLY SIRONA Inc Stakeholders Are Invited By The Schall Law Firm To Participate In The XRAY Probe

LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.

DENTSPLY SIRONA Inc Stakeholders Are Invited By The Schall Law Firm To Participate In The XRAY Probe

See News Rankings